Pharmacy Disclosure Log 2025

  1. Asthma Response 1003
  2. Asthma Response 1003 Attachment
  3. Biologics - Dermatology Response 1046
  4. Biologics Gastro Response 1128
  5. Biologics Rheumatology Response 1057
  6. Atopic Dermatitis Response 981
  7. Biologic Medicines in Gastroenterology Response 847
  8. Biologics Rheumatology Response 762
  9. Blood Cultures Response 940
  10. Curosurf and Peyona Response 1110
  11. Dermatology and Respiratory Medicine Response 977
  12. Dermatology Response 771
  13. Diffuse Large B Cell Lymphoma Response 827
  14. Endometrial Cancer Response 923
  15. Eosinophilic Oesophagitis (EoE) Response 972
  16. Elastomeric Infusion Devices Response 1031
  17. Fibrinogen Concentrate, Prothrombin Complex Concentrate, DOAC Antidote, and Blood Products Response 772
  18. Fibrinogen Concentrate, Prothrombin Complex Concentrate, DOAC Antidote, and blood Products Response 772 Attachment
  19. Formularies and Committees Response 941
  20. Friedreich Ataxia Response 921
  21. Gastroenterology Response 1156
  22. Giant Cell Arteritis Response 1083
  23. Human Albumin Response 826
  24. Immunoglobulin Treatment Response 932
  25. Intra-Vitreal Injections Implants Response 810
  26. Intra-vitreal treatments Response 870
  27. Intra-Vitreal Injections or Implants Response 1066
  28. Intra-Vitreal Treatments Response 1145
  29. Lung Cancer Response 1148
  30. Lung Cancer Response 864
  31. Lung Cancer Response 864 Attachment
  32. Medication errors Rocuronium Response 918
  33. Melanoma Response 901
  34. Migraine Response 856
  35. New Biologic and Targeted Medications Response 867
  36. Non-Medical uses of Blood Response 802
  37. NHS Pharmacy Aseptic Services Response 803
  38. Oncology Breast Cancer Response 857
  39. Oncology Response 928
  40. Ovarian Cancer Response 944
  41. Patients treated with Ruxolitinib Response 933
  42. Patients treated with Ruxolitinib Response 933 Attachment
  43. Primary Diagnosis of GCA Response 784
  44. Renal Cell Carcinoma Response 871
  45. Renal Cell Carcinoma Response 871 Attachment
  46. Spinal Muscular Atrophy Response 794
  47. Trust Processes to Reduce Medication Waste Response 885
  48. Urothelial Cancer Response 930
  49. Wound Formulary Response 860